Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Abbott Laboratories : DECLARES 387TH CONSECUTIVE QUARTERLY DIVIDEND

share with twitter share with LinkedIn share with facebook
09/18/2020 | 09:59am EDT

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share.

This marks the 387th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 16, 2020, to shareholders of record at the close of business on Oct. 15, 2020.

Abbott has increased its dividend payout for 48 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott:

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 107,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.

Contact:

Tel: 224-668-0791

(C) 2020 Electronic News Publishing, source ENP Newswire


share with twitter share with LinkedIn share with facebook
All news about ABBOTT LABORATORIES
07:04aUnited to give travelers free COVID-19 tests on select Newark-London flights
RE
10/28Combined Market Cap of Five Largest MedTech Companies Surged by $40bn YoY
AQ
10/28JPMorgan appoints General Dynamics CEO as board member
RE
10/28Boston Scientific reports loss as COVID-19 slams demand for medical devices
RE
10/23GLOBAL MARKETS LIVE : Intel, Mattel, NordeaÖ
10/22Quest raises profit forecast as COVID-19 tests demand to jump
RE
10/22ABBOTT LABORATORIES : Reports third-quarter 2020 results, achieves strong double..
AQ
10/21ABBOTT LABORATORIES : Raises 2020 Earnings Guidance
DJ
10/21ABBOTT LABORATORIES : 3Q Profit, Sales Rise on Covid-19 Testing
DJ
10/21Abbott says COVID-19 test demand to grow in 2021
RE
More news
Financials (USD)
Sales 2020 33 885 M - -
Net income 2020 4 415 M - -
Net Debt 2020 11 438 M - -
P/E ratio 2020 42,9x
Yield 2020 1,38%
Capitalization 186 B 186 B -
EV / Sales 2020 5,82x
EV / Sales 2021 5,07x
Nbr of Employees 107 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 117,78 $
Last Close Price 105,00 $
Spread / Highest target 23,8%
Spread / Average Target 12,2%
Spread / Lowest Target -21,9%
EPS Revisions
Managers
NameTitle
Robert B. Ford President, CEO, Chief Operating Officer & Director
Miles D. White Executive Chairman
Robert E. Funck Chief Financial Officer & Executive Vice President
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES20.88%188 420
MEDTRONIC PLC-9.57%137 923
BECTON, DICKINSON AND COMPANY-13.27%68 377
HOYA CORPORATION20.86%45 978
BAXTER INTERNATIONAL INC.-6.54%39 562
SARTORIUS STEDIM BIOTECH120.31%35 264